- Home
- ARCT vs SPXX Comparison
ARCT vs SPXX Comparison
Compare ARCT & SPXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARCT | SPXX |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.9M | 340.5M |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ARCT | SPXX |
|---|---|---|
| Price | $10.74 | $18.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $23.80 | N/A |
| AVG Volume (30 Days) | ★ 653.3K | 237.8K |
| Earning Date | 11-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $64.21 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.50 | $15.78 |
| 52 Week High | $17.96 | $19.39 |
Technical Indicators
Market Signals| Indicator | ARCT | SPXX |
|---|---|---|
| Relative Strength Index (RSI) | 38.81 | 45.11 |
| Support Level | $6.53 | $18.23 |
| Resistance Level | $17.85 | $18.92 |
| Average True Range (ATR) | 1.13 | 0.24 |
| MACD | -0.26 | 0.01 |
| Stochastic Oscillator | 8.84 | 17.24 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on approximately 35% to 75% of the notional value of the Fund's equity portfolio in an effort to enhance the Fund's risk-adjusted returns.